Samil Pharmaceutical Co., Ltd. (000520) Ratios

― Followers

Samil Pharmaceutical Co., Ltd. Ratios

KR:000520's free cash flow for Q2 2026 was ₩0.33. For the 2026 fiscal year, KR:000520's free cash flow was decreased by ₩ and operating cash flow was ₩-0.13. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	0.48	0.44	0.86	0.48	0.56
Quick Ratio	0.28	0.25	0.53	0.29	0.38
Cash Ratio	0.04	0.03	0.05	<0.01	0.01
Solvency Ratio	-0.10	-0.09	<0.01	0.03	0.02
Operating Cash Flow Ratio	>-0.01	-0.03	0.02	0.07	0.03
Short-Term Operating Cash Flow Coverage	>-0.01	-0.04	0.04	0.09	0.05
Net Current Asset Value	₩ -172.93B	₩ -156.38B	₩ -127.60B	₩ -161.74B	₩ -156.10B
Leverage Ratios
Debt-to-Assets Ratio	0.47	0.44	0.38	0.47	0.45
Debt-to-Equity Ratio	1.40	1.23	0.85	1.38	1.27
Debt-to-Capital Ratio	0.58	0.55	0.46	0.58	0.56
Long-Term Debt-to-Capital Ratio	0.29	0.14	0.32	0.28	0.36
Financial Leverage Ratio	2.98	2.79	2.24	2.90	2.84
Debt Service Coverage Ratio	-0.28	-0.05	0.10	0.08	0.10
Interest Coverage Ratio	-3.41	-2.73	0.02	1.83	0.94
Debt to Market Cap	1.01	0.79	0.62	1.78	1.41
Interest Debt Per Share	8.65K	8.13K	8.63K	12.53K	11.75K
Net Debt to EBITDA	-4.32	-14.70	16.74	16.93	15.26
Profitability Margins
Gross Profit Margin	32.13%	32.06%	36.83%	36.78%	37.56%
EBIT Margin	-14.66%	-11.38%	0.66%	2.53%	2.96%
EBITDA Margin	-18.97%	-5.10%	3.94%	5.26%	5.74%
Operating Profit Margin	-14.53%	-11.38%	0.05%	3.30%	2.24%
Pretax Profit Margin	-19.07%	-17.66%	-1.64%	0.73%	0.59%
Net Profit Margin	-18.09%	-16.44%	-2.56%	0.85%	-0.02%
Continuous Operations Profit Margin	-18.09%	-16.44%	-2.56%	0.85%	-0.02%
Net Income Per EBT	94.86%	93.09%	155.81%	116.84%	-2.67%
EBT Per EBIT	131.24%	155.23%	-3195.87%	22.00%	26.34%
Return on Assets (ROA)	-10.02%	-9.31%	-1.42%	0.45%	>-0.01%
Return on Equity (ROE)	-28.30%	-25.96%	-3.20%	1.30%	-0.02%
Return on Capital Employed (ROCE)	-14.07%	-12.84%	0.04%	3.20%	1.79%
Return on Invested Capital (ROIC)	-8.48%	-6.80%	0.03%	1.98%	-0.03%
Return on Tangible Assets	-10.16%	-9.45%	-1.44%	0.45%	>-0.01%
Earnings Yield	-21.58%	-16.80%	-2.38%	1.70%	-0.03%
Efficiency Ratios
Receivables Turnover	5.85	5.64	6.14	5.48	5.26
Payables Turnover	9.72	7.45	7.24	5.91	8.21
Inventory Turnover	4.43	4.10	3.99	3.82	4.53
Fixed Asset Turnover	0.83	0.87	0.87	0.81	0.77
Asset Turnover	0.55	0.57	0.56	0.53	0.50
Working Capital Turnover Ratio	-2.40	-3.55	-4.27	-2.70	-3.50
Cash Conversion Cycle	107.27	104.76	100.50	100.41	105.49
Days of Sales Outstanding	62.42	64.75	59.44	66.58	69.44
Days of Inventory Outstanding	82.40	89.02	91.44	95.60	80.50
Days of Payables Outstanding	37.55	49.01	50.39	61.76	44.44
Operating Cycle	144.82	153.77	150.89	162.17	149.93
Cash Flow Ratios
Operating Cash Flow Per Share	-1.22	-285.20	144.02	820.11	298.52
Free Cash Flow Per Share	-347.77	-636.15	-168.06	-882.91	-3.20K
CapEx Per Share	346.55	350.95	312.08	1.70K	3.50K
Free Cash Flow to Operating Cash Flow	284.54	2.23	-1.17	-1.08	-10.71
Dividend Paid and CapEx Coverage Ratio	>-0.01	-0.81	0.46	0.48	0.08
Capital Expenditure Coverage Ratio	>-0.01	-0.81	0.46	0.48	0.09
Operating Cash Flow Coverage Ratio	>-0.01	-0.04	0.02	0.07	0.03
Operating Cash Flow to Sales Ratio	>-0.01	-0.03	0.01	0.06	0.02
Free Cash Flow Yield	-4.27%	-6.57%	-1.28%	-12.89%	-39.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-4.59	-5.95	-42.01	58.97	-3.96K
Price-to-Sales (P/S) Ratio	0.83	0.98	1.08	0.50	0.62
Price-to-Book (P/B) Ratio	1.38	1.54	1.34	0.77	0.89
Price-to-Free Cash Flow (P/FCF) Ratio	-23.29	-15.23	-78.25	-7.76	-2.52
Price-to-Operating Cash Flow Ratio	-6.63K	-33.98	91.31	8.35	26.95
Price-to-Earnings Growth (PEG) Ratio	0.08	-0.01	0.11	-0.01	39.79
Price-to-Fair Value	1.38	1.54	1.34	0.77	0.89
Enterprise Value Multiple	-8.72	-33.90	44.04	26.42	26.12
Enterprise Value	343.90B	363.49B	381.42B	273.08B	269.31B
EV to EBITDA	-8.74	-33.90	44.04	26.42	26.12
EV to Sales	1.66	1.73	1.74	1.39	1.50
EV to Free Cash Flow	-46.27	-26.89	-126.21	-21.60	-6.05
EV to Operating Cash Flow	-13.17K	-59.99	147.27	23.25	64.83
Tangible Book Value Per Share	5.62K	6.01K	9.49K	8.73K	8.82K
Shareholders’ Equity Per Share	5.87K	6.27K	9.79K	8.93K	9.04K
Tax and Other Ratios
Effective Tax Rate	0.05	0.07	-0.56	-0.17	1.03
Revenue Per Share	9.71K	9.90K	12.22K	13.71K	12.91K
Net Income Per Share	-1.76K	-1.63K	-313.01	116.15	-2.03
Tax Burden	0.95	0.93	1.56	1.17	-0.03
Interest Burden	1.30	1.55	-2.50	0.29	0.20
Research & Development to Revenue	0.03	0.04	0.03	0.03	0.02
SG&A to Revenue	0.27	0.20	0.16	0.31	0.16
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	<0.01	0.17	-0.46	7.06	-146.85

Currency in KRW